Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04117724 · ClinicalTrials.gov registry record

Antibiotic Adherence Practices in Dermatologic Surgery

A clinical trial of Medication Adherence, sponsored by University of Pennsylvania.

Completed
Registry status
276
Enrollment target
9
Study locations

NCT04117724: Completed study of Medication Adherence, sponsored by University of Pennsylvania.

NCT04117724 is a study of Medication Adherence that has completed, run by University of Pennsylvania. The registered enrollment target is 276 participants, below the 1,652-participant average among 52 other Medication Adherence trials with a reported enrollment target (83% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04117724, a study of Medication Adherence, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
276 participants
Enrollment target
9
Study locations

Study Summary

This multi-center prospective observational cohort study will examine the prevalence of non-adherence along with analyze the risk factors of non-adherence for patients presenting to dermatologic surgery. Patients prescribed antibiotics will be invited to participate in the study and appropriate follow up to inquire about antibiotic usage will be conducted. All data will be collected and stored in a secured REDCap database managed by the Penn Dermatologic Surgery Clinical Research Team.

Primary Outcome

To analyze the prevalence of antibiotic non-adherence in the dermatologic surgery setting

Conditions Studied

Interventions

  • OTHER Survey

Study Locations (9)

Missouri

  • University of Missouri Health Care - Columbia
  • Washington University in St. Louis - St Louis

California

  • University of California, Davis - Davis

Indiana

  • Indiana University - Indianapolis

Minnesota

  • University of Minnesota - Minneapolis

Ohio

  • The Ohio State University - Columbus

Oregon

  • Oregon Health & Science University - Portland

Pennsylvania

  • Penn State Health Milton S. Hershey Medical Center - Hershey

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2019-10-10
Est. Completion 2021-05-01
University of Pennsylvania

1,423 total trials

What the finished NCT04117724 record still lists

NCT04117724 is an observational study that tracks outcomes without assigning an intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 1,652-participant average among 52 other Medication Adherence trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.

NCT04117724 lists 9 locations in 8 states (Missouri, California, Indiana).

Frequently Asked Questions

What is clinical trial NCT04117724 about?

NCT04117724 is a clinical study titled "Antibiotic Adherence Practices in Dermatologic Surgery". This multi-center prospective observational cohort study will examine the prevalence of non-adherence along with analyze the risk factors of non-adherence for patients presenting to dermatologic surgery. Patients prescribed antibiotics will be invited to participate in the study and appropriate foll...

What is the current status of trial NCT04117724?

This trial is currently completed. The enrollment target is 276 participants. The study started on 2019-10-10. Estimated completion is 2021-05-01.

What conditions does trial NCT04117724 study?

This clinical trial studies the following conditions: Medication Adherence.

What interventions are being tested in trial NCT04117724?

The interventions under investigation include: Survey (OTHER).

Who is sponsoring clinical trial NCT04117724?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04117724 being conducted?

This trial has 9 study locations across California, Indiana, Minnesota, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Medication Adherence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04117724's enrollment target sits among peer trials

276 16th of 52 higher than 37 of 52 other Medication Adherence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Medication Adherence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01371630 · 276 participants · Phase 1

    Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

  • NCT04192344 · 276 participants · Phase 1

    A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

  • NCT05294991 · 276 participants · NA

    Wellness App for Sleep Disturbance in Hematological Cancer Patients

  • NCT05610852 · 276 participants · NA

    Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04117724, the US trial registry maintained by the National Library of Medicine. NCT04117724 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.